In ALL, overexpression of PKCα did not affect cell proliferation, cell cycle, or activation of mitogen-activated protein kinases (MAPKs), but increased chemoresistance through Bcl-2 activation [28]. The gene discussed is PRKCA; the disease is acute lymphoblastic leukemia.